mYXpression
mYXpression is a biodigital platform company founded in 2016 and based in Dijon, France, specializing in precision medicine solutions for autoimmune diseases. It offers innovative AI-driven and multiomic analysis technologies to support biopharmaceutical companies in developing biomedicines and to assist healthcare professionals in prescribing these treatments more effectively. Its key products include the RITI® test, which aids in prescribing biotherapies for autoimmune diseases, and predictive AI tools to reduce clinical study risks. The company leverages a proprietary database of over 20 million profiles and advanced RNA sequencing technology to provide personalized therapeutic efficacy scores. mYXpression is engaged in clinical trials to validate its solutions and aims to transform healthcare by making precision medicine accessible to patients, physicians, and biotechs.
mYXpression
mYXpression is a biodigital platform company founded in 2016 and based in Dijon, France, specializing in precision medicine solutions for autoimmune diseases. It offers innovative AI-driven and multiomic analysis technologies to support biopharmaceutical companies in developing biomedicines and to assist healthcare professionals in prescribing these treatments more effectively. Its key products include the RITI® test, which aids in prescribing biotherapies for autoimmune diseases, and predictive AI tools to reduce clinical study risks. The company leverages a proprietary database of over 20 million profiles and advanced RNA sequencing technology to provide personalized therapeutic efficacy scores. mYXpression is engaged in clinical trials to validate its solutions and aims to transform healthcare by making precision medicine accessible to patients, physicians, and biotechs.